Chong Kun Dang Holdings

Chong Kun Dang Holdings is a South Korean company that specializes in the manufacture and marketing of pharmaceutical products and active pharmaceutical ingredients. The company provides a range of offerings, including prescription medications, over-the-counter drugs, dietary supplements, and consumer health items. Its primary focus is on improving human health and extending life through the development of effective medicines. Chong Kun Dang operates primarily within South Korea, where it plays a significant role in the pharmaceutical industry.

Jang-han Rhee

CEO

2 past transactions

Nodit

Series A in 2020
# Nodit Nodit is a Web3 development platform specialized in blockchain data. Nodit aims to provide enterprise-grade multi-chain Web3 infrastructure accessible to everyone. By offering reliable node infrastructure with 99.9% uptime and consistent ready-to-query blockchain data at an affordable price, we are facilitating developers’ entry into the Web3 world. # Lambda256 Lambda256, the blockchain tech arm of Dunamu, developed and operates Nodit, which enhances efficiency in managing tasks like blockchain network setup, node operation, and data processing for Ethereum, Arbitrum, and Aptos and Luniverse, a cloud-based blockchain infrastructure platform. Lambda256 also offers a travel rule solution to meet FATF guidelines, improving security and compliance for virtual asset transactions. The company secured Series A funding, followed by Series B funding in December 2021, achieving a total accumulated investment of approximately +80 million USD.

BIORCHESTRA

Venture Round in 2019
BIORCHESTRA is a biotech company that develops RNA-based therapeutics for treating neuroinflammatory diseases. They focus on changing the therapeutic paradigm from treating the symptoms to providing a fundamental cure for diseases. BIORCHESTRA develops neuroinflammatory disease therapeutics, with a particular emphasis on comprehensive patient care. BIORCHESTRA's complementary discovery platforms range from diagnosis to treatment monitoring.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.